{"entity":{"id":"nct07824986","kind":"trial","name":"A Phase 3 Trial in Advanced Epithelioid Mesothelioma","aka":[],"tldr":"A phase 3 trial of VT3989 run by Vivace Therapeutics, Inc, not yet recruiting.","summary":"A Phase 3 Trial in Advanced Epithelioid Mesothelioma is a phase 3 interventional study registered as NCT07824986 by Vivace Therapeutics, Inc, with 350 participants planned, started 2026-12-01, primary completion expected 2028-05-01. Conditions recorded: Pleural Mesothelioma, Mesothelioma. Interventions recorded: VT3989, gemcitabine, Vinorelbine.","status":"planned","asOf":"2026-11-04","links":[{"label":"ClinicalTrials.gov NCT07824986","url":"https://clinicaltrials.gov/study/NCT07824986"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["pleural-mesothelioma","mesothelioma"],"sections":[],"technologies":[],"targets":[],"drugs":["vt3989"],"companies":["vivace-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07824986","phase":"3","setting":"A Phase 3, Randomized, Open-label Trial Comparing VT3989 Versus Gemcitabine or Vinorelbine in Participants With Advanced Epithelioid Mesothelioma, Who Previously Received Platinum-Based Systemic Chemotherapy and Immunotherapy","sponsor":"Vivace Therapeutics, Inc","enrolled":350,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07824986/","neighbours":{"cancer":[{"id":"mesothelioma","kind":"cancer","name":"Mesothelioma","route":"/cancers/mesothelioma/"},{"id":"pleural-mesothelioma","kind":"cancer","name":"Pleural mesothelioma","route":"/cancers/pleural-mesothelioma/"}],"drug":[{"id":"vt3989","kind":"drug","name":"VT3989","route":"/drugs/vt3989/"}],"company":[{"id":"vivace-therapeutics","kind":"company","name":"Vivace Therapeutics","route":"/companies/vivace-therapeutics/"}]}}